OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Young‐Yun Kong, Hiroki Yoshida(University of Toronto), Ildiko Sarosi(Amgen (United States)), Hong‐Lin Tan(Amgen (United States)), Emma Timms(Amgen (United States)), Casey Capparelli(Amgen (United States)), Sean Morony(Amgen (United States)), Antonio Oliveira-dos-Santos(Ontario Institute for Cancer Research), Gwyneth Van(Amgen (United States)), Annick Itié(University of Toronto), Wilson Khoo(Ontario Institute for Cancer Research), Andrew Wakeham(Amgen (Canada)), Colin R. Dunstan(Amgen (United States)), David L. Lacey(Amgen (United States)), Tak W. Mak(Ontario Institute for Cancer Research), William J. Boyle(Amgen (United States)), Josef Penninger(Ontario Institute for Cancer Research)
Cited by 3,356